Not only are biotech stocks subject to the boom-or-bust nature of their therapeutics, but they also operate in a cyclical ...

Dark Blue Therapeutics, a UK discovery and development biotech developing precision oncology medicines, has announced the appointment of Edwin Moses as chairman.

Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...

Additional details are included in, and the description above is qualified in its entirety by, AIM's Current Report on Form 8 ...

AIM ImmunoTech Inc. ("AIM" or the "Company") (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: Good day, everyone, and welcome to the Vivos Therapeutics Full Year ...

Researchers found a protein that's essential for an enterovirus to enter human cells. Although not the infamous example—that ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

A 40-gene expression profile test can improve risk stratification for patients with CSCC, according to researchers.

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...